CD274 (PD‐L1)/PDCD1 (PD‐1) expression in de novo and transformed diffuse large B‐cell lymphoma

Blombery, P., Thompson, E. , Jones, K. , Mir Arnau, G. , Lade, S. , Markham, J.F. , Li, J., Deva, A. , Johnstone, R.W. , Khot, A. , Prince, H.M. & Westerman, D. (2016) Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell. Haematologica, 101, e387–e390. Clemens, M.W. , Medeiros, L.J., Butler, C.E. , Hunt, K.K. , Fanale, M.A., Horwitz, S. , Weisenburger, D.D. , Liu, J., Morgan, E.A. , Kanagal-Shamanna, R. , Parkash, V. , Ning, J., Sohani, A.R. , Ferry, J.A. , Mehta-Shah, N. , Dogan, A. , Liu, H. , Thormann, N. , Di Napoli, A. , Lade, S. , Piccolini, J., Reyes, R. , Williams, T. , McCarthy, C.M. , Hanson, S.E. , Nastoupil, L.J., Gaur, R. , Oki, Y. , Young, K.H. & Miranda, R.N. (2016) Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. Journal of Clinical Oncology, 34, 160–168. Crescenzo, R. , Abate, F. , Lasorsa, E. , Tabbo’, F. , Gaudiano, M. , Chiesa, N. , Di Giacomo, F. , Spaccarotella, E. , Barbarossa, L. , Ercole, E. , Todaro, M. , Boi, M. , Acquaviva, A. , Ficarra, E. , Novero, D. , Rinaldi, A. , Tousseyn, T. , Rosenwald, A. , Kenner, L. , Cerroni, L. , Tzankov, A. , Ponzoni, M. , Paulli, M. , Weisenburger, D. , Chan, W.C. , Iqbal, J., Piris, M.A., Zamo’, A. , Ciardullo, C. , Rossi, D. , Gaidano, G. , Pileri, S. , Tiacci, E. , Falini, B. , Shultz, L.D. , Mevellec, L. , Vialard, J.E. , Piva, R. , Bertoni, F. , Rabadan, R. & Inghirami, G. (2015) Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell, 27, 516–532. Lechner, M.G. , Megiel, C. , Church, C.H. , Angell, T.E. , Russell, S.M. , Sevell, R.B. , Jang, J.K. , Brody, G.S. & Epstein, A.L. (2012) Survival signals and targets for therapy in breast implant-associated ALK-anaplastic large cell lymphoma. Clinical Cancer Research, 18, 4549–4559. Merkel, O. , Hamacher, F. , Griessl, R. , Grabner, L. , Schiefer, A.I., Prutsch, N. , Baer, C. , Egger, G. , Schlederer, M. , Krenn, P.W. , Hartmann, T.N. , Simonitsch-Klupp, I. , Plass, C. , Staber, P.B. , Moriggl, R. , Turner, S.D. , Greil, R. & Kenner, L. (2015) Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation. Journal of Pathology, 236, 445–456. Mottok, A. , Renn e, C. , Seifert, M. , Oppermann, E. , Bechstein, W. , Hansmann, M.L. , K€ uppers, R. & Br€auninger, A. (2009) Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities. Blood, 114, 4503–4506. Odejide, O. , Weigert, O. , Lane, A.A. , Toscano, D. , Lunning, M.A., Kopp, N. , Kim, S. , van Bodegom, D. , Bolla, S. , Schatz, J.H. , Teruya-Feldstein, J., Hochberg, E. , Louissaint, A. , Dorfman, D. , Stevenson, K. , Rodig, S.J., Piccaluga, P.P., Jacobsen, E. , Pileri, S.A. , Harris, N.L. , Ferrero, S. , Inghirami, G. , Horwitz, S.M. & Weinstock, D.M. (2014) A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood, 123, 1293–1296. Petitjean, A. , Mathe, E. , Kato, S. , Ishioka, C. , Tavtigian, S.V. , Hainaut, P. & Olivier, M. (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database (database version R18, April 2016). Human Mutation, 28, 622–629. Swerdlow, S.H. , Campo, E. , Pileri, S.A. , Harris, N.L. , Stein, H. , Siebert, R. , Advani, R. , Ghielmini, M. , Salles, G.A. , Zelenetz, A.D. & Jaffe, E.S. (2016) The 2016 revision to the World Health Organization classification of lymphoid neoplasm. Blood, 127, 2375–2390. Yang, L. , Rau, R. & Goodell, M.A. (2015) DNMT3A in haematological malignancies. Nature Reviews Cancer, 15, 152–165.